1. Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate

   • Fausto Petrelli
   • Sandro Barni

   Original Paper 02 March 2010 Pages: 401 - 408

2. Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey

   • Gul Basaran
   • Nazım Serdar Turhal
   • Perran Fulden Yumuk

   Original Paper 20 March 2010 Pages: 409 - 415

   

3. Prolonged time to progression with fulvestrant for metastatic breast cancer

   • Celso A. L. Mello
   • Ludmilla T. D. Chinen
   • Marcello F. Fanelli

   Original Paper 20 March 2010 Pages: 416 - 419

   

4. Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation

   • Vallian Sadeq
   • Nassiri Isar
   • Tavassoli Manoochehr

   Original Paper 17 March 2010 Pages: 420 - 423

   

5. Lack of significant association between TGF-β1 -590C/T polymorphism and breast cancer risk: a meta-analysis

   • Yongsheng Huang
   • Youjin Hao
   • Long Yu

   Original Paper 27 March 2010 Pages: 424 - 428

   

6. Experience in large-core needle biopsy in the diagnosis of 1431 breast lesions

   • Xi Wei
   • Ying Li
   • Yu Fan

   Original Paper 26 March 2010 Pages: 429 - 433

   

7. A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer

   • Kenji Hashimoto
   • Kan Yonemori
   • Yasuhiro Fujiwara

   Original Paper 31 March 2010 Pages: 434 - 440

8. Reproductive factors associated with breast cancer risk in northern Iran

   • K. O. Hajian-Tilaki
   • T. Kaveh-Ahangar

   Original paper 03 April 2010 Pages: 441 - 446

9. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer

   • Shi-Lian Hu
   • Da-Bing Huang
   • Gan Shen

   Original Paper 19 March 2010 Pages: 447 - 454

   

10. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer

    • Xu Jian-bo
    • Wu Hui
    • Zhan Wen-hua

    OriginalPaper 19 March 2010 Pages: 455 - 462

    

11. Painless acute pancreatitis associated with sorafenib treatment: a case report

    • Yasuyuki Kobayashi
    • Toshiyuki Kanemitu
    • Takashi Fujimoto

    Original Paper 19 March 2010 Pages: 463 - 465

    

12. Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer

    • Xiaohui Duan
    • Langmei Deng
    • Weijia Sun

    Original Paper 31 March 2010 Pages: 466 - 474

    

13. ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients

    • Kai Wu
    • Mingmei Liao
    • Zhansheng Deng

    Original Paper 19 March 2010 Pages: 475 - 480

    

14. Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma

    • Jin Zhang
    • Wei-guo Dong
    • Jun Lin

    Original Paper 31 March 2010 Pages: 481 - 487

    

15. Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy

    • Hironori Fujii
    • Hirotoshi Iihara
    • Yoshinori Itoh

    Original Paper 31 March 2010 Pages: 488 - 493

16. Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA

    • Jin Zhang
    • Qi-Sheng Liu
    • Wei-Guo Dong

    Original Paper 15 April 2010 Pages: 494 - 501

    

17. Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes

    • Bo Tang
    • Zhi-Hong Peng
    • Feng Qian

    Original Paper 06 April 2010 Pages: 502 - 508

    

18. Neuroendocrine carcinoma of the esophagus: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA

    • Tadashi Terada

    Original Paper 31 March 2010 Pages: 509 - 512

    

19. The clinical relevance of urine-based markers for diagnosis of bladder cancer

    • Sanaa Eissa
    • Menha Swellam
    • Tarek Mostafa El-Zayat

    Original Paper 25 March 2011 Pages: 513 - 518

    

20. Health-related quality of life assessment in prospective trials of systemic cytotoxic chemotherapy for metastatic castration-resistant prostate cancer: which instrument we need?

    • Giuseppe Colloca
    • Pasquale Colloca

    Original paper 31 March 2010 Pages: 519 - 527

21. Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death

    • Rui Chen
    • Wei Xiao
    • Shijie Mu

    Original Paper 31 March 2010 Pages: 528 - 531

    

22. Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia

    • Matthew S. Kaufman
    • Angelica Caramanica
    • Kanti R. Rai

    Original Paper 17 March 2010 Pages: 532 - 538

23. Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma

    • Maciej Machaczka
    • Johan Vaktnäs
    • Hans Hägglund

    Original Paper 01 April 2010 Pages: 539 - 543

    

24. Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features

    • Pradeep S. Chauhan
    • Bharat Bhushan
    • Sujala Kapur

    Original Paper 31 March 2010 Pages: 544 - 551

    

25. Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts

    • Anders Wahlin
    • Fryderyk Lorenz
    • Hans Hägglund

    Original Paper 15 April 2010 Pages: 552 - 558

    

26. Metastin is not involved in metastatic potential of non-small cell lung cancer

    • Eleni M. Karapanagiotou
    • Kalliopi D. Dilana
    • Kostas N. Syrigos

    Original paper 06 March 2010 Pages: 559 - 564

    

27. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549

    • Fang Zhu
    • Zhe Zhang
    • Li Nong

    OriginalPaper 19 March 2010 Pages: 565 - 571

    

28. BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer

    • Zhanxia Li
    • Songwen Zhou
    • Caicun Zhou

    Original Paper 17 March 2010 Pages: 572 - 577

    

29. Sunitinib in pretreated advanced non-small-cell lung carcinoma: a primary result from Asian population

    • Gu Ping
    • Wang Hui-Min
    • Han Bao-Hui

    Original paper 31 March 2010 Pages: 578 - 583

    

30. Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study

    • Nirmeen A. Sabry
    • Emad E. Habib

    Original Paper 05 March 2010 Pages: 584 - 590

31. Gemcitabine and cisplatin in patients with carcinoma of unknown primary site

    • Metin Isik
    • Mehmet M. Seker
    • Nurullah Zengin

    Original Paper 19 March 2010 Pages: 591 - 596

32. The invasive malignancy from peritoneal epithelial cell: a report of four cases and review of literature

    • Xue Hongjian
    • Fan Jiquan
    • Cao Rubo

    Original Paper 19 March 2010 Pages: 597 - 600

33. Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells

    • Zhisen Shen
    • Zhen Jiang
    • Junming Guo

    Original Paper 19 March 2010 Pages: 601 - 607

    

34. β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells

    • Xiangrong Liu
    • Lei Wang
    • Feng Ling

    Original Paper 19 March 2010 Pages: 608 - 614

    

35. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats

    • Mustafa Paksoy
    • Emin Ayduran
    • Zeynep Alev Oktay

    Original Paper 19 March 2010 Pages: 615 - 621

    

36. Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population

    • Yun-Sheng Hu
    • Yong Pan
    • Bao-An Ma

    Original Paper 31 March 2010 Pages: 622 - 625

37. EpCAM-autoantibody levels in the course of disease of ovarian cancer patients

    • Martin Heubner
    • Dino Errico
    • Pauline Wimberger

    Original Paper 10 April 2010 Pages: 626 - 630

    

38. The role of Pygopus 2 in rat glioma cell growth

    • Yu-ying Chen
    • Bo-an Li
    • Zhan-xiang Wang

    Original Paper 02 April 2010 Pages: 631 - 640

    

39. Golimumab and malignancies: true or false association?

    • Ines Zidi
    • Aicha Bouaziz
    • Nidhal Ben Amor

    Original Paper 07 April 2010 Pages: 641 - 648

    

40. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

    • Feng Lin
    • Shui-er Zheng
    • Yang Yao

    Original Paper 27 March 2010 Pages: 649 - 653